Digital mammography with AI-based computer-aided diagnosis to predict neoadjuvant chemotherapy response in HER2-positive and triple-negative breast cancer patients: comparison with MRI

Citations

WEB OF SCIENCE

4

초록

Objective To investigate whether digital mammography (DM) with artificial intelligence-based computer-aided diagnosis (AI-CAD) predicts pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) in human epidermal growth factor receptor 2 (HER2)-positive and triple-negative (TN) breast cancers and compare performance with dynamic contrast-enhanced (DCE)-MRI. Materials and methods In this single-center study, patients who underwent NAC and surgery for HER2-positive or TN cancers between September 2020 and August 2021 were retrospectively selected to develop prediction models for pCR after NAC. From a prospective ASLAN (Avoid axillary Sentinel Lymph node biopsy After Neoadjuvant chemotherapy) trial, HER2-positive and TN cancer patients who underwent NAC and surgery between December 2021 and July 2022 were prospectively selected for model validation. Clinical-pathologic data and DM and MRI scans were obtained before and after NAC. Logistic regression analyses identified factors associated with pCR for model development and four models (clinical-pathologic, MRI, DM-AI-CAD, and combined) were evaluated. Results A total of 259 women (mean age, 53 years +/- 10.5 [SD]) constituted the development cohort and 119 (50.8 years +/- 11.1) the validation cohort. Age, clinical N stage, estrogen receptor, progesterone receptor, and Ki-67 were incorporated into the clinical-pathologic model. In the validation cohort, the DM-AI-CAD model, applying AI-CAD score <= 16 on post-NAC DM as the radiologic CR criterion, showed a higher area under the receiver operating characteristic curve (AUC) compared to the clinical-pathologic model (0.72 vs. 0.62; p = 0.01) for pCR. However, the MRI model showed the highest AUC (0.83), then the combined model (0.78). Conclusion The model utilizing post-NAC DM with AI-CAD score <= 16 predicted pCR more accurately than the clinical-pathologic model in HER2-positive and TN cancers but was inferior to the MRI model.

키워드

Breast neoplasm; Neoadjuvant therapy; Magnetic resonance imaging; Mammography; Artificial intelligence; PATHOLOGICAL COMPLETE RESPONSE; THERAPY
제목
Digital mammography with AI-based computer-aided diagnosis to predict neoadjuvant chemotherapy response in HER2-positive and triple-negative breast cancer patients: comparison with MRI
저자
Kim, Haejung; Choi, Ji Soo; Chi, Sang Ah; Ryu, Jai Min; Lee, Jeong Eon; Kim, Myoung Kyoung; Lee, Jeongmin; Ko, Eun Sook; Ko, Eun Young; Han, Boo-Kyung
DOI
10.1007/s00330-025-11390-x
발행일
2025-09
유형
Article
저널명
European Radiology
권
35
호
9
페이지
5671 ~ 5684